Stroke

Acute ischaemic stroke, the most common type of stroke, occurs when the blood supply to part of the brain is blocked by either a blood clot in a brain vessel or atherosclerosis (fatty deposits or plaques lining vessel walls). A stroke can lead to disability or even death and always requires quick, acute treatment. Boehringer Ingelheim led the way in stroke care by developing the only licensed blood clot dissolving treatment (thrombolytic) for acute ischaemic stroke therapy, which is now used in stroke centres worldwide. Boehringer Ingelheim also sponsors the angels initiative: a programme that helps doctors to set up and optimise acute stroke networks with the support of local and international stroke societies.

Latest Articles

stroke_dont_stay_at_home

Stroke, don’t stay at home!

Learn why the Angels Initiative is urging anyone who experiences stroke symptoms to seek immediate medical care, even during the pandemic

Making Every Second Count
Honouring_ERT
Stroke

Making Every Second Count

The Angels Initiative honours emergency response teams making every second count for patients
Read more